Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IART |
---|---|---|
09:32 ET | 26804 | 39.765 |
09:34 ET | 7844 | 40.02 |
09:36 ET | 3218 | 40.24 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Integra Lifesciences Holdings Corp | 3.2B | 19.5x | +9.60% |
Enovis Corp | 3.1B | -124.9x | --- |
Conmed Corp | 3.9B | -38.8x | --- |
LivaNova PLC | 2.5B | -30.3x | --- |
Agiliti Inc | 2.3B | 174.2x | +25.38% |
NuVasive Inc | 2.1B | 150.5x | -8.93% |
Integra LifeSciences Holdings Corporation is a medical technology company. The Company operates through two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS segment consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield and Bactiseal. Its product offering includes CereLink in the Unites States and Europe. The Company’s TT segment focuses on three areas, which include complex wound surgery, surgical reconstruction and peripheral nerve repair. TT's regenerative platform includes multiple brands, such as Integra Dermal Matrices, AmnioExcel, SurgiMend, MicroMatrix and NeuraGen. The Company's manufacturing and research facilities are located in California, Indiana, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, Utah, France, Germany, Ireland and Switzerland.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2B |
---|---|
Revenue (TTM) | $1.6B |
Shares Outstanding | 81.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.16 |
EPS | $2.07 |
Book Value | $21.57 |
P/E Ratio | 19.5x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | 10.9x |
Operating Margin | 14.39% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.